PRCT insider sale: 6,892 shares for $163K

PRCT reports an insider sale and a planned issuance of common stock.

Accepted by SEC EDGAR 03/17/2026 - 03:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PRCT reports an insider sale and a planned issuance of common stock. Alaleh Nouri sold 6,892 shares of Common Stock on 03/06/2026 for $163,353.49. The filing also lists 304 shares of Common Stock issued for compensation (restricted stock vesting) on 03/16/2026.

Insights

Corporate Governance Analyst

Routine Form 144 sale and a compensation-related vesting event.

The filing records a reported sale of 6,892 shares by Alaleh Nouri on 03/06/2026

and a separate issuance of 304 restricted shares vested as compensation on 03/16/2026

Equity Transactions Specialist

Transaction appears administrative rather than transformational for PRCT.

The sale value is listed as $163,353.49, and a broker (Fidelity Brokerage Services LLC) is named. The items recorded are routine selling and compensation events; cash‑flow treatment for the 304 shares is described as Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PRCT insider Alaleh Nouri report in Form 144?

Alaleh Nouri reported selling 6,892 shares of Common Stock on 03/06/2026 for $163,353.49. The Form 144 lists that sale alongside an unrelated compensation vesting entry for 304 shares on 03/16/2026.

Does the filing show any newly issued shares for PRCT?

Yes. The filing lists 304 shares of Common Stock issued as restricted stock vesting for compensation on 03/16/2026, with the issuer identified as the recipient of those shares in the record.

What broker is listed for the reported PRCT transaction?

The broker shown is Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI. The broker entry appears in the securities/broker section associated with the transaction details in the filing.

How much cash was reported for the insider sale in PRCT's filing?

The reported proceeds for the sale of 6,892 shares are $163,353.49, tied to the trade dated 03/06/2026. The filing lists that dollar figure alongside the share count for the reported sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001599418
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCEPT BioRobotics Corp
SEC File Number	001-40797
Address of Issuer	150 BAYTECH DRIVE SAN JOSE CALIFORNIA 95134
Phone	6502329832
Name of Person for Whose Account the Securities are To Be Sold	Nouri Alaleh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	304	8558.57	56390196	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Restricted Stock Vesting	Issuer			304	03/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alaleh Nouri 150 Baytech Drive San Jose CA 95134	Common	03/06/2026	6892	163353.49

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alaleh Nouri
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)